Roche’s current business arrangements with Genentech give Roche all non-US marketing and development rights to Genentech’s product line through 2015. While that may seem a long way off to some people, Genentech apparently has as many as 100 products in it’s current development pipeline, and as these products move into clinical trials, the ability to [...]
Filed under: Uncategorized | Comments Off
